Department of Urology
Leonard S. Marks has not added Biography.
If you are Leonard S. Marks and would like to personalize this page please email our Author Liaison for assistance.
The interpretation of serum prostate specific antigen in men receiving 5alpha-reductase inhibitors: a review and clinical recommendations.
The Journal of urology Sep, 2006 | Pubmed ID: 16890642
Prevention of benign prostatic hyperplasia disease.
The Journal of urology Oct, 2006 | Pubmed ID: 16952616
Editorial comment.
The Journal of urology May, 2008 | Pubmed ID: 18343450
A multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range.
The Journal of urology May, 2011 | Pubmed ID: 21419439
Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device.
The Journal of urology Jan, 2013 | Pubmed ID: 23158413
Prospective multicenter evaluation of the Beckman Coulter Prostate Health Index using WHO calibration.
The Journal of urology May, 2013 | Pubmed ID: 23206426
Targeted prostate biopsy in select men for active surveillance: do the Epstein criteria still apply?
The Journal of urology Aug, 2014 | Pubmed ID: 24512956
Improving risk stratification in patients with prostate cancer managed by active surveillance: nomogram predicting the risk of biopsy progression.
BJU international Apr, 2014 | Pubmed ID: 24629086
Screening and detection advances in magnetic resonance image-guided prostate biopsy.
The Urologic clinics of North America May, 2014 | Pubmed ID: 24725492
Clinical validation of an epigenetic assay to predict negative histopathological results in repeat prostate biopsies.
The Journal of urology Oct, 2014 | Pubmed ID: 24747657
Magnetic resonance imaging-ultrasound fusion biopsy for prediction of final prostate pathology.
The Journal of urology Nov, 2014 | Pubmed ID: 24793118
Initial experience with electronic tracking of specific tumor sites in men undergoing active surveillance of prostate cancer.
Urologic oncology Oct, 2014 | Pubmed ID: 25027689
A system for evaluating magnetic resonance imaging of prostate cancer using patient-specific 3D printed molds.
American journal of clinical and experimental urology , 2014 | Pubmed ID: 25374914
The prostate health index selectively identifies clinically significant prostate cancer.
The Journal of urology Apr, 2015 | Pubmed ID: 25463993
Does the addition of targeted prostate biopsies to standard systemic biopsies influence treatment management for radiation oncologists?
BJU international Apr, 2016 | Pubmed ID: 25684394
MRI-Derived Restriction Spectrum Imaging Cellularity Index is Associated with High Grade Prostate Cancer on Radical Prostatectomy Specimens.
Frontiers in oncology , 2015 | Pubmed ID: 25741473
Multiparametric magnetic resonance imaging for prostate cancer improves Gleason score assessment in favorable risk prostate cancer.
Practical radiation oncology Nov-Dec, 2015 | Pubmed ID: 26059510
Targeted Prostate Biopsy: Lessons Learned Midst the Evolution of a Disruptive Technology.
Urology Sep, 2015 | Pubmed ID: 26166671
Serial Magnetic Resonance Imaging in Active Surveillance of Prostate Cancer: Incremental Value.
The Journal of urology May, 2016 | Pubmed ID: 26674305
Focal Laser Ablation of Prostate Cancer: Phase I Clinical Trial.
The Journal of urology 07, 2016 | Pubmed ID: 26748164
The Relationship between Intolerance of Uncertainty and Anxiety in Men on Active Surveillance for Prostate Cancer.
The Journal of urology 06, 2016 | Pubmed ID: 26872841
Prostate cancer risk stratification with magnetic resonance imaging.
Urologic oncology 07, 2016 | Pubmed ID: 27040381
Magnetic Resonance Imaging Underestimation of Prostate Cancer Geometry: Use of Patient Specific Molds to Correlate Images with Whole Mount Pathology.
The Journal of urology 02, 2017 | Pubmed ID: 27484386
Targeted Biopsy to Detect Gleason Score Upgrading during Active Surveillance for Men with Low versus Intermediate Risk Prostate Cancer.
The Journal of urology 03, 2017 | Pubmed ID: 27639713
Focal Laser Ablation of Prostate Cancer.
Urology Jan, 2017 | Pubmed ID: 27720973
Prostate Health Index improves multivariable risk prediction of aggressive prostate cancer.
BJU international 07, 2017 | Pubmed ID: 27743489
Molecular Profiling to Determine Clonality of Serial Magnetic Resonance Imaging/Ultrasound Fusion Biopsies from Men on Active Surveillance for Low-Risk Prostate Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research Feb, 2017 | Pubmed ID: 28031426
Re: A Pilot Study to Evaluate the Role of Magnetic Resonance Imaging for Prostate Cancer Screening in the General Population.
European urology 06, 2017 | Pubmed ID: 28233592
The First Filmed Prostatectomy, 1917: 100 Years of Movies in Urological Education.
Urology Jul, 2017 | Pubmed ID: 28363740
Focal Laser Ablation of Prostate Cancer: Feasibility of Magnetic Resonance Imaging-Ultrasound Fusion for Guidance.
The Journal of urology 10, 2017 | Pubmed ID: 28396184
High Intensity Focused Ultrasound for Radiorecurrent Prostate Cancer: A North American Clinical Trial.
The Journal of urology 01, 2018 | Pubmed ID: 28652121
Value of Tracking Biopsy in Men Undergoing Active Surveillance of Prostate Cancer.
The Journal of urology 01, 2018 | Pubmed ID: 28728993
Focal Therapy Eligibility Determined by Magnetic Resonance Imaging/Ultrasound Fusion Biopsy.
The Journal of urology 02, 2018 | Pubmed ID: 28830754
Targeted Prostate Biopsy in the Era of Active Surveillance.
Urology Feb, 2018 | Pubmed ID: 28962878
Development of a Nationally Representative Coordinated Registry Network for Prostate Ablation Technologies.
The Journal of urology 06, 2018 | Pubmed ID: 29307684
Editorial Comment.
The Journal of urology 04, 2018 | Pubmed ID: 29360445
A 17-Gene Genomic Prostate Score Assay Provides Independent Information on Adverse Pathology in the Setting of Combined Multiparametric Magnetic Resonance Imaging Fusion Targeted and Systematic Prostate Biopsy.
The Journal of urology 09, 2018 | Pubmed ID: 29524506
Exclusive MRI-targeted biopsy: not so fast.
The Lancet. Oncology Jan, 2019 | Pubmed ID: 30470503
Targeted and Systematic Biopsy for Diagnosis and Management of Prostate Cancer.
Clinical oncology (Royal College of Radiologists (Great Britain)) 03, 2020 | Pubmed ID: 31864796
An Electronic Form for Reporting Results of Targeted Prostate Biopsy: Urology Integrated Diagnostic Report (Uro-IDR).
Urology Apr, 2020 | Pubmed ID: 31978527
Editorial Comment.
The Journal of urology 03, 2021 | Pubmed ID: 33393830
Utilization of focal therapy for patients discontinuing active surveillance of prostate cancer: Recommendations of an international Delphi consensus.
Urologic oncology Mar, 2021 | Pubmed ID: 33676851
关于 JoVE
版权所属 © 2024 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。